The health benefits of olive oil in cardiovascular disease prevention: An update Georgia Samakidou, Nikolaos Katsilambros, Nikolaos Tentolouris, Evangelos Liberopoulos
Antidiabetic drugs in patients with Covid-19 infection Konstantinos Theocharis, Christina Antza, Georgios Kostopoulos, Vasilios Kotsis
Higher COVID-19 outbreak in countries with lower cardiovascular disease mortality, in Europe Demosthenes Panagiotakos, Alexandra Tragaki
Non-alcoholic fatty liver disease in HIV – infected patients without viral hepatitis What can we do about their cardiovascular risk G. Sfikas, Chr. Boutari, K. Tassios, K. Kaitanidis, E. Mitsiou, V.G. Athyros
Comparative effectiveness of acenocoumarol and low-dose dabigatran in patients with atrial fibrillation and recent ischemic stroke in everyday clinical practice Konstantinos Tziomalos, Vasilios Giampatzis, Stella D. Bouziana, Marianna Spanou, Stavroula Kostaki, Maria Papadopoulou, Stella-Maria Angelopoulou, Filitsa Konstantara, Christos Savopoulos, Apostolos I. Hatzitolios
Non-alcoholic fatty liver disease in HIV-infected patients without viral hepatitis. What can we do about their cardiovascular risk? Georgios Sfikas, Chrysoula Boutari, Konstandinos Tassios, Konstantinos Kaitanidis, Eydoxia Mitsiou, Vasilios G. Athyros
Novel roles of vitamin D in pathogenesis of cardiovascular disease Stefania Makariou, Evangelos N Liberopoulos, Anna Challa